ALGS
Price
$7.21
Change
+$1.17 (+19.34%)
Updated
Jun 6, 04:09 PM (EDT)
Capitalization
36.99M
ARWR
Price
$16.93
Change
+$0.47 (+2.86%)
Updated
Jun 6, 04:10 PM (EDT)
Capitalization
2.27B
66 days until earnings call
Interact to see
Advertisement

ALGS vs ARWR

Header iconALGS vs ARWR Comparison
Open Charts ALGS vs ARWRBanner chart's image
Aligos Therapeutics
Price$7.21
Change+$1.17 (+19.34%)
Volume$2.5K
Capitalization36.99M
Arrowhead Pharmaceuticals
Price$16.93
Change+$0.47 (+2.86%)
Volume$320
Capitalization2.27B
ALGS vs ARWR Comparison Chart
Loading...
ALGS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALGS vs. ARWR commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGS is a Buy and ARWR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (ALGS: $6.05 vs. ARWR: $16.45)
Brand notoriety: ALGS: Not notable vs. ARWR: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALGS: 49% vs. ARWR: 76%
Market capitalization -- ALGS: $36.99M vs. ARWR: $2.27B
ALGS [@Biotechnology] is valued at $36.99M. ARWR’s [@Biotechnology] market capitalization is $2.27B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGS’s FA Score shows that 1 FA rating(s) are green whileARWR’s FA Score has 1 green FA rating(s).

  • ALGS’s FA Score: 1 green, 4 red.
  • ARWR’s FA Score: 1 green, 4 red.
According to our system of comparison, both ALGS and ARWR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGS’s TA Score shows that 5 TA indicator(s) are bullish while ARWR’s TA Score has 5 bullish TA indicator(s).

  • ALGS’s TA Score: 5 bullish, 2 bearish.
  • ARWR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ALGS is a better buy in the short-term than ARWR.

Price Growth

ALGS (@Biotechnology) experienced а +5.49% price change this week, while ARWR (@Biotechnology) price change was -2.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.61%. For the same industry, the average monthly price growth was +17.33%, and the average quarterly price growth was +3.50%.

Reported Earning Dates

ALGS is expected to report earnings on Mar 10, 2025.

ARWR is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+11.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARWR($2.27B) has a higher market cap than ALGS($37M). ARWR YTD gains are higher at: -12.500 vs. ALGS (-84.814). ALGS has higher annual earnings (EBITDA): -83.89M vs. ARWR (-580.69M). ARWR has more cash in the bank: 553M vs. ALGS (138M). ALGS has less debt than ARWR: ALGS (7.87M) vs ARWR (525M). ALGS has higher revenues than ARWR: ALGS (3.27M) vs ARWR (2.5M).
ALGSARWRALGS / ARWR
Capitalization37M2.27B2%
EBITDA-83.89M-580.69M14%
Gain YTD-84.814-12.500679%
P/E RatioN/AN/A-
Revenue3.27M2.5M131%
Total Cash138M553M25%
Total Debt7.87M525M1%
FUNDAMENTALS RATINGS
ARWR: Fundamental Ratings
ARWR
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALGSARWR
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
72%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
70%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend about 1 month ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
ALGS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRVS3.900.15
+4.13%
Corvus Pharmaceuticals
ASO42.900.10
+0.23%
Academy Sports and Outdoors
LGL6.610.01
+0.15%
LGL Group (The)
IDXX522.21-2.65
-0.50%
IDEXX Laboratories
ANGI16.60-0.38
-2.27%
Angi Inc

ALGS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGS has been loosely correlated with XNCR. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGS jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGS
1D Price
Change %
ALGS100%
+1.68%
XNCR - ALGS
41%
Loosely correlated
+0.22%
STRO - ALGS
39%
Loosely correlated
-9.37%
RLAY - ALGS
36%
Loosely correlated
N/A
CRNX - ALGS
35%
Loosely correlated
+0.59%
ARWR - ALGS
33%
Loosely correlated
-1.73%
More

ARWR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARWR has been loosely correlated with DNLI. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ARWR jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARWR
1D Price
Change %
ARWR100%
-1.73%
DNLI - ARWR
54%
Loosely correlated
-1.35%
RGNX - ARWR
53%
Loosely correlated
-17.36%
YMAB - ARWR
53%
Loosely correlated
+3.02%
BEAM - ARWR
52%
Loosely correlated
-0.87%
VERV - ARWR
50%
Loosely correlated
+8.22%
More